|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7276 USD | -2.01% |
|
-5.51% | +1.48% |
| 05-14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
| 05-13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
VolitionRx Limited filed its 10-K on Mar 15, 2023 for the period ending Dec 31, 2022. In this report its auditor, Sadler, Gibb and Associates, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.48% | 60.26M | |
| -32.63% | 9.2B | |
| -5.66% | 3.12B | |
| -18.33% | 2.05B | |
| -24.39% | 1.59B | |
| +65.65% | 1.44B | |
| +32.83% | 830M | |
| -6.77% | 720M | |
| -29.80% | 507M | |
| +0.40% | 297M |
VOLITIONRX LIMITED 
